Realcan Pharmaceutical Group Co Ltd
SZSE:002589
Realcan Pharmaceutical Group Co Ltd
SZSE:002589
Price:
3.59
CNY
10.12%
Market Cap:
¥5.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Realcan Pharmaceutical Group Co Ltd
SZSE:002589
|
CN |
|
Coca-Cola Europacific Partners PLC
NASDAQ:CCEP
|
UK |
|
O
|
Old Mutual Ltd
JSE:OMU
|
ZA |
|
S
|
Samtex Fashions Ltd
BSE:521206
|
IN |
|
J
|
Jiangxi Hungpai New Material Co Ltd
SSE:605366
|
CN |
|
PayGroup Ltd
ASX:PYG
|
AU |
|
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
|
US |
|
G
|
Genedrive PLC
LSE:GDR
|
UK |
Multiples-Based Value
The Multiples-Based Value of one
Realcan Pharmaceutical Group Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 3.59 CNY,
Realcan Pharmaceutical Group Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Realcan Pharmaceutical Group Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Realcan Pharmaceutical Group Co Ltd Competitors
Realcan Pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Realcan Pharmaceutical Group Co Ltd
SZSE:002589
|
5.4B CNY | 0.7 | -893.2 | -181.2 | -181.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
106.2B USD | 0.3 | 24.5 | 17.2 | 19.3 | |
| US |
|
Cencora Inc
NYSE:COR
|
61.8B USD | 0.2 | 38.1 | 13.5 | 17 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.2B USD | 0.2 | 38.3 | 13.5 | 17.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50B USD | 0.2 | 30.1 | 14.5 | 18.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.1B AUD | 2.7 | 34.4 | 25.5 | 25.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64B CNY | 0.2 | 11.2 | 8.7 | 8.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.6B CNY | 1.5 | 16.9 | 13.1 | 13.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 0.7 | 22.5 | 11.1 | 15.6 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65B HKD | 0.1 | 8.1 | 0.7 | 0.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
